InvestorsHub Logo
Followers 77
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: noretreat post# 1016

Friday, 08/11/2017 7:36:55 AM

Friday, August 11, 2017 7:36:55 AM

Post# of 3970
Look at yesterday's report.
All trials going well but they are long term - none of the approval will come in 2018.

So only the 2 products will give some revenue. If you read the announcements at the time of deal - the yearly revenue at peak is not very large - only in few millions - in teens

I am afraid - unless there is partnership or BO - this stock will remain below 10 and when overall market turns bad - this will deep faster giving better buying opportunity.

They are spending high amount of funds on many big trials.

H priori trial - 65 sites - 400+ patients - at least 1 year - so filing cannot be before Q1-2019
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RDHL News